Cutaneous features of pseudoxanthoma elasticum in a patient with generalized arterial calcification of infancy due to a homozygous missense mutation in the ENPP1 gene.

PubWeight™: 1.27‹?› | Rank: Top 10%

🔗 View Article (PMC 3336007)

Published in Br J Dermatol on April 04, 2012

Authors

Q Li1, W Schumacher, D Jablonski, D Siegel, J Uitto

Author Affiliations

1: Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, PA 19107, USA.

Articles citing this

ABCC6 prevents ectopic mineralization seen in pseudoxanthoma elasticum by inducing cellular nucleotide release. Proc Natl Acad Sci U S A (2013) 1.31

Generalized arterial calcification of infancy and pseudoxanthoma elasticum: two sides of the same coin. Front Genet (2012) 1.21

Mineralization/anti-mineralization networks in the skin and vascular connective tissues. Am J Pathol (2013) 1.18

Mutant Enpp1asj mice as a model for generalized arterial calcification of infancy. Dis Model Mech (2013) 1.17

Mutations in the ABCC6 gene as a cause of generalized arterial calcification of infancy: genotypic overlap with pseudoxanthoma elasticum. J Invest Dermatol (2013) 1.10

Pseudoxanthoma elasticum and skin: Clinical manifestations, histopathology, pathomechanism, perspectives of treatment. Intractable Rare Dis Res (2015) 0.98

Fibroblast involvement in soft connective tissue calcification. Front Genet (2013) 0.94

The effects of bisphosphonates on ectopic soft tissue mineralization caused by mutations in the ABCC6 gene. Cell Cycle (2015) 0.93

Ectopic mineralization disorders of the extracellular matrix of connective tissue: molecular genetics and pathomechanisms of aberrant calcification. Matrix Biol (2013) 0.92

A novel animal model for pseudoxanthoma elasticum: the KK/HlJ mouse. Am J Pathol (2012) 0.91

Zebrafish enpp1 mutants exhibit pathological mineralization, mimicking features of generalized arterial calcification of infancy (GACI) and pseudoxanthoma elasticum (PXE). Dis Model Mech (2014) 0.91

ENPP1-Fc prevents mortality and vascular calcifications in rodent model of generalized arterial calcification of infancy. Nat Commun (2015) 0.86

Warfarin accelerates ectopic mineralization in Abcc6(-/-) mice: clinical relevance to pseudoxanthoma elasticum. Am J Pathol (2013) 0.84

Clinical phenotypes and ABCC6 gene mutations in Brazilian families with pseudoxanthoma elasticum. Acta Derm Venereol (2013) 0.83

Paediatric pseudoxanthoma elasticum with cardiovascular involvement. Br J Dermatol (2013) 0.80

From variome to phenome: Pathogenesis, diagnosis and management of ectopic mineralization disorders. World J Clin Cases (2015) 0.79

Genetic heterogeneity of pseudoxanthoma elasticum: the Chinese signature profile of ABCC6 and ENPP1 mutations. J Invest Dermatol (2015) 0.78

Perturbation of specific pro-mineralizing signalling pathways in human and murine pseudoxanthoma elasticum. Orphanet J Rare Dis (2014) 0.78

Changes in dermal fibroblasts from Abcc6(-/-) mice are present before and after the onset of ectopic tissue mineralization. J Invest Dermatol (2014) 0.77

Research Progress in Pseudoxanthoma Elasticum and Related Ectopic Mineralization Disorders. J Invest Dermatol (2016) 0.76

Dual Effects of Bisphosphonates on Ectopic Skin and Vascular Soft Tissue Mineralization versus Bone Microarchitecture in a Mouse Model of Generalized Arterial Calcification of Infancy. J Invest Dermatol (2016) 0.76

Heritable ectopic mineralization disorders: the paradigm of pseudoxanthoma elasticum. J Invest Dermatol (2012) 0.76

Heart transplant and 2-year follow up in a child with generalized arterial calcification of infancy. Eur J Pediatr (2014) 0.75

Articles cited by this

Pseudoxanthoma elasticum. Clin Dermatol (1988) 2.79

Pseudoxanthoma elasticum-like phenotype with cutis laxa and multiple coagulation factor deficiency represents a separate genetic entity. J Invest Dermatol (2006) 2.76

Pseudoxanthoma elasticum: molecular genetics and putative pathomechanisms. J Invest Dermatol (2009) 2.43

Mutation detection in the ABCC6 gene and genotype-phenotype analysis in a large international case series affected by pseudoxanthoma elasticum. J Med Genet (2007) 2.32

Hypophosphatemia, hyperphosphaturia, and bisphosphonate treatment are associated with survival beyond infancy in generalized arterial calcification of infancy. Circ Cardiovasc Genet (2008) 1.93

Mutations in the GGCX and ABCC6 genes in a family with pseudoxanthoma elasticum-like phenotypes. J Invest Dermatol (2008) 1.52

Familial tumoral calcinosis: from characterization of a rare phenotype to the pathogenesis of ectopic calcification. J Invest Dermatol (2009) 1.51

Genetics in arterial calcification: pieces of a puzzle and cogs in a wheel. Circ Res (2011) 1.46

The mutational spectrum of ENPP1 as arising after the analysis of 23 unrelated patients with generalized arterial calcification of infancy (GACI). Hum Mutat (2005) 1.42

An unusual severe vascular case of pseudoxanthoma elasticum presenting as generalized arterial calcification of infancy. Am J Med Genet A (2010) 1.35

Co-existent pseudoxanthoma elasticum and vitamin K-dependent coagulation factor deficiency: compound heterozygosity for mutations in the GGCX gene. Am J Pathol (2008) 1.24

Acquired Pseudoxanthoma elasticum-like syndrome in beta-thalassaemia patients. Br J Haematol (2003) 1.20

Haplotype structure of the ENPP1 Gene and Nominal Association of the K121Q missense single nucleotide polymorphism with glycemic traits in the Framingham Heart Study. Diabetes (2008) 1.15

A patient with hypophosphatemic rickets and ossification of posterior longitudinal ligament caused by a novel homozygous mutation in ENPP1 gene. Bone (2011) 1.05

Generalized arterial calcification of infancy: phenotypic spectrum among three siblings including one case without obvious arterial calcifications. Am J Med Genet A (2009) 1.02

Characterization of pseudoxanthoma elasticum-like lesions in the skin of patients with beta-thalassemia. J Am Acad Dermatol (2001) 0.99

Manifestations of pseudoxanthoma elasticum in childhood. Br J Dermatol (2009) 0.92

Pseudoxanthoma-elasticum-like syndrome and thalassemia: an update. Dermatol Online J (2009) 0.91

Elastosis perforans serpiginosa associated with pseudo-pseudoxanthoma elasticum during treatment of Wilson's disease with penicillamine. Dermatology (2005) 0.89

Matrix Gla protein polymorphism, but not concentrations, is associated with radiographic hand osteoarthritis. J Rheumatol (2011) 0.84

L-tryptophan-induced eosinophilia-myalgia syndrome. I. Report of two cases with pseudoxanthoma-elasticum-like skin changes. Dermatologica (1991) 0.81

Salpeter-induced dermal changes electron-microscopically indistinguishable from pseudoxanthoma elasticum. Acta Derm Venereol (1978) 0.81

Articles by these authors

(truncated to the top 100)

Effects of sampling standardization on estimates of Phanerozoic marine diversification. Proc Natl Acad Sci U S A (2001) 5.27

Marine latitudinal diversity gradients: tests of causal hypotheses. Proc Natl Acad Sci U S A (1998) 5.05

Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study. Leukemia (2011) 4.47

Onshore-offshore patterns in the evolution of phanerozoic shelf communities. Science (1983) 4.32

A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma. Br J Haematol (2004) 3.49

Eastern Pacific molluscan provinces and latitudinal diversity gradient: no evidence for "Rapoport's rule". Proc Natl Acad Sci U S A (1994) 3.34

Background and mass extinctions: the alternation of macroevolutionary regimes. Science (1986) 2.88

Condom use in multi-ethnic neighborhoods of San Francisco: the population-based AMEN (AIDS in Multi-Ethnic Neighborhoods) Study. Am J Public Health (1992) 2.71

NAD(P)H:quinone oxidoreductase 1 (NQO1): chemoprotection, bioactivation, gene regulation and genetic polymorphisms. Chem Biol Interact (2000) 2.60

Dehalobacter restrictus gen. nov. and sp. nov., a strictly anaerobic bacterium that reductively dechlorinates tetra- and trichloroethene in an anaerobic respiration. Arch Microbiol (1998) 2.53

First direct observation of a nearly ideal graphene band structure. Phys Rev Lett (2009) 2.41

Novel function for beta 1 integrins in keratinocyte cell-cell interactions. J Cell Biol (1990) 2.39

International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma. Leukemia (2009) 2.28

Targeted disruption of the pemphigus vulgaris antigen (desmoglein 3) gene in mice causes loss of keratinocyte cell adhesion with a phenotype similar to pemphigus vulgaris. J Cell Biol (1997) 2.23

The mechanism of respiratory failure in paraneoplastic pemphigus. N Engl J Med (1999) 2.21

Heritability at the species level: analysis of geographic ranges of cretaceous mollusks. Science (1987) 2.10

NAD(P)H:Quinone oxidoreductase activity is the principal determinant of beta-lapachone cytotoxicity. J Biol Chem (2000) 1.99

Pseudoxanthoma elasticum: mutations in the MRP6 gene encoding a transmembrane ATP-binding cassette (ABC) transporter. Proc Natl Acad Sci U S A (2000) 1.97

Revised classification system for inherited epidermolysis bullosa: Report of the Second International Consensus Meeting on diagnosis and classification of epidermolysis bullosa. J Am Acad Dermatol (2000) 1.97

Comparison of nerve cell and nerve cell plus Schwann cell cultures, with particular emphasis on basal lamina and collagen formation. J Cell Biol (1980) 1.96

Dissecting latitudinal diversity gradients: functional groups and clades of marine bivalves. Proc Biol Sci (2000) 1.91

Environmental patterns in the origins of higher taxa: the post-paleozoic fossil record. Science (1991) 1.90

Integrin beta 4 mutations associated with junctional epidermolysis bullosa with pyloric atresia. Nat Genet (1995) 1.90

Total therapy with tandem transplants for newly diagnosed multiple myeloma. Blood (1999) 1.89

Plectin deficiency results in muscular dystrophy with epidermolysis bullosa. Nat Genet (1996) 1.78

Reductive dehalogenation as a respiratory process. Antonie Van Leeuwenhoek (1994) 1.77

Geography of end-Cretaceous marine bivalve extinctions. Science (1993) 1.76

Intrinsic aging vs. photoaging: a comparative histopathological, immunohistochemical, and ultrastructural study of skin. Exp Dermatol (2002) 1.75

Mutations in cornea-specific keratin K3 or K12 genes cause Meesmann's corneal dystrophy. Nat Genet (1997) 1.75

Loss of plectin causes epidermolysis bullosa with muscular dystrophy: cDNA cloning and genomic organization. Genes Dev (1996) 1.75

Scleroderma: increased biosynthesis of triple-helical type I and type III procollagens associated with unaltered expression of collagenase by skin fibroblasts in culture. J Clin Invest (1979) 1.73

Connective tissue nevi of the skin. Clinical, genetic, and histopathologic classification of hamartomas of the collagen, elastin, and proteoglycan type. J Am Acad Dermatol (1980) 1.71

Mutations in the 180-kD bullous pemphigoid antigen (BPAG2), a hemidesmosomal transmembrane collagen (COL17A1), in generalized atrophic benign epidermolysis bullosa. Nat Genet (1995) 1.71

Mutation analysis and molecular genetics of epidermolysis bullosa. Matrix Biol (1999) 1.70

Extinctions: a paleontological perspective. Science (1991) 1.70

Management of treatment-emergent peripheral neuropathy in multiple myeloma. Leukemia (2011) 1.70

Human elastin gene: new evidence for localization to the long arm of chromosome 7. Am J Hum Genet (1991) 1.69

Altered laminin 5 expression due to mutations in the gene encoding the beta 3 chain (LAMB3) in generalized atrophic benign epidermolysis bullosa. J Invest Dermatol (1995) 1.69

Cloning of type XVII collagen. Complementary and genomic DNA sequences of mouse 180-kilodalton bullous pemphigoid antigen (BPAG2) predict an interrupted collagenous domain, a transmembrane segment, and unusual features in the 5'-end of the gene and the 3'-untranslated region of the mRNA. J Biol Chem (1993) 1.69

Oligoclonal protein bands and Ig isotype switching in multiple myeloma treated with high-dose therapy and hematopoietic cell transplantation. Blood (1998) 1.68

Fossils, molecules and embryos: new perspectives on the Cambrian explosion. Development (1999) 1.68

Human type VII collagen: cDNA cloning and chromosomal mapping of the gene. Proc Natl Acad Sci U S A (1991) 1.66

Mutations in the gamma 2 chain gene (LAMC2) of kalinin/laminin 5 in the junctional forms of epidermolysis bullosa. Nat Genet (1994) 1.65

Herlitz's junctional epidermolysis bullosa is linked to mutations in the gene (LAMC2) for the gamma 2 subunit of nicein/kalinin (LAMININ-5). Nat Genet (1994) 1.63

Regulation of IFN-gamma induction in human peripheral blood cells by exogenous and endogenously produced interleukin 2. J Immunol (1985) 1.62

The impact of diuretic therapy on reported sexual function. Arch Intern Med (1991) 1.61

Targeted inactivation of the type VII collagen gene (Col7a1) in mice results in severe blistering phenotype: a model for recessive dystrophic epidermolysis bullosa. J Cell Sci (1999) 1.61

Vertebral artery dissection and pontine infarct after chiropractic manipulation. Am J Emerg Med (2001) 1.60

A homozygous nonsense mutation in the beta 3 chain gene of laminin 5 (LAMB3) in Herlitz junctional epidermolysis bullosa. Genomics (1994) 1.59

DT-diaphorase in activation and detoxification of quinones. Bioreductive activation of mitomycin C. Cancer Metastasis Rev (1993) 1.58

Revertant mosaicism in epidermolysis bullosa caused by mitotic gene conversion. Cell (1997) 1.57

Nicaragua: a health system developing under conditions of war. Int J Health Serv (1987) 1.57

Increased collagen cross-linkages in experimental diabetes: reversal by beta-aminopropionitrile and D-penicillamine. Diabetes (1980) 1.56

Human bullous pemphigoid antigen (BPAG1). Amino acid sequences deduced from cloned cDNAs predict biologically important peptide segments and protein domains. J Biol Chem (1991) 1.55

trans-dominant inhibition of connexin-43 by mutant connexin-26: implications for dominant connexin disorders affecting epidermal differentiation. J Cell Sci (2001) 1.54

A missense mutation in type VII collagen in two affected siblings with recessive dystrophic epidermolysis bullosa. Nat Genet (1993) 1.53

Localization of integrin receptors for fibronectin, collagen, and laminin in human skin. Variable expression in basal and squamous cell carcinomas. J Clin Invest (1989) 1.52

An AP-1 binding sequence is essential for regulation of the human alpha2(I) collagen (COL1A2) promoter activity by transforming growth factor-beta. J Biol Chem (1996) 1.52

Cloning of human type VII collagen. Complete primary sequence of the alpha 1(VII) chain and identification of intragenic polymorphisms. J Biol Chem (1994) 1.51

Smad3/AP-1 interactions control transcriptional responses to TGF-beta in a promoter-specific manner. Oncogene (2001) 1.51

A molecular defect in loricrin, the major component of the cornified cell envelope, underlies Vohwinkel's syndrome. Nat Genet (1996) 1.47

Differential regulation of extracellular matrix proteoglycan (PG) gene expression. Transforming growth factor-beta 1 up-regulates biglycan (PGI), and versican (large fibroblast PG) but down-regulates decorin (PGII) mRNA levels in human fibroblasts in culture. J Biol Chem (1991) 1.46

The cause and pathogenesis of the eosinophilia-myalgia syndrome. Ann Intern Med (1992) 1.46

Aminophylline increases the toxicity but not the efficacy of an inhaled beta-adrenergic agonist in the treatment of acute exacerbations of asthma. Am Rev Respir Dis (1985) 1.44

Genetic linkage analysis of hereditary arthro-ophthalmopathy (Stickler syndrome) and the type II procollagen gene. Am J Hum Genet (1989) 1.44

Protection against pemphigus foliaceus by desmoglein 3 in neonates. N Engl J Med (2000) 1.43

Structural organization of the human type VII collagen gene (COL7A1), composed of more exons than any previously characterized gene. Genomics (1994) 1.43

Characterization of a polymorphism in NAD(P)H: quinone oxidoreductase (DT-diaphorase). Br J Cancer (1997) 1.42

Further evaluation of the significance of urinary hydroxyproline determinations in the diagnosis of thyroid disorders. Clin Chim Acta (1968) 1.41

Characterization of the complete human elastin gene. Delineation of unusual features in the 5'-flanking region. J Biol Chem (1989) 1.40

Invariant size-frequency distributions along a latitudinal gradient in marine bivalves. Proc Natl Acad Sci U S A (2000) 1.40

A 500-kb region on chromosome 16p13.1 contains the pseudoxanthoma elasticum locus: high-resolution mapping and genomic structure. J Mol Med (Berl) (2000) 1.39

Elevated DT-diaphorase activity and messenger RNA content in human non-small cell lung carcinoma: relationship to the response of lung tumor xenografts to mitomycin Cł. Cancer Res (1992) 1.38

New technique for treating occlusive and stenosing tumours of the trachea and main bronchi: endobronchial irradiation by high dose iridium-192 combined with laser canalisation. Thorax (1987) 1.38

The utility of follow-up testing after curative cancer therapy. A critical review and economic analysis. J Gen Intern Med (1997) 1.37

Risk for AIDS in multiethnic neighborhoods in San Francisco, California. The population-based AMEN Study. West J Med (1992) 1.35

Determinants of condom use among junior high school students in a minority, inner-city school district. Pediatrics (1992) 1.35

Connective tissue biochemistry of the aging dermis. Age-related alterations in collagen and elastin. Dermatol Clin (1986) 1.34

Smokeless tobacco use and health effects among baseball players. JAMA (1990) 1.33

Formation of interchain disulfide bonds and helical structure during biosynthesis of procollagen by embryonic tendon cells. Biochemistry (1974) 1.33

Continuous non-therapeutic use of antibacterial drugs in feed and drug resistance of the gram-negative enteric florae of food-producing animals. Antimicrob Agents Chemother (1974) 1.30

Protocollagen proline hydroxylase activity in the skin of normal human subjects and of patients with scleroderma. Scand J Clin Lab Invest (1969) 1.30

The members of the plakin family of proteins recognized by paraneoplastic pemphigus antibodies include periplakin. J Invest Dermatol (1998) 1.30

Bioactivation of quinones by DT-diaphorase, molecular, biochemical, and chemical studies. Oncol Res (1994) 1.29

Epidermolysis bullosa. I. Molecular genetics of the junctional and hemidesmosomal variants. J Med Genet (2006) 1.29

Genetic linkage of recessive dystrophic epidermolysis bullosa to the type VII collagen gene. J Clin Invest (1992) 1.29

A mutation in human keratin K6b produces a phenocopy of the K17 disorder pachyonychia congenita type 2. Hum Mol Genet (1998) 1.28

Molecular complexity of the cutaneous basement membrane zone. Revelations from the paradigms of epidermolysis bullosa. Exp Dermatol (1996) 1.28

Interleukin-10 modulates type I collagen and matrix metalloprotease gene expression in cultured human skin fibroblasts. J Clin Invest (1994) 1.28

Keratin 17 mutations cause either steatocystoma multiplex or pachyonychia congenita type 2. Br J Dermatol (1998) 1.28

Premature termination codons in the type VII collagen gene (COL7A1) underlie severe, mutilating recessive dystrophic epidermolysis bullosa. Genomics (1994) 1.28

Developmental evolution of metazoan bodyplans: the fossil evidence. Dev Biol (1996) 1.28

Pharmacokinetic study of netilmicin. Antimicrob Agents Chemother (1977) 1.28

Activation of collagen gene expression in keloids: co-localization of type I and VI collagen and transforming growth factor-beta 1 mRNA. J Invest Dermatol (1991) 1.25

Progress in epidermolysis bullosa: the phenotypic spectrum of plectin mutations. Exp Dermatol (2005) 1.25

Classification of pseudoxanthoma elasticum: report of a consensus conference. J Am Acad Dermatol (1994) 1.25

Reduction of collagen production in keloid fibroblast cultures by ethyl-3,4-dihydroxybenzoate. Inhibition of prolyl hydroxylase activity as a mechanism of action. J Biol Chem (1987) 1.25

A homozygous insertion-deletion in the type VII collagen gene (COL7A1) in Hallopeau-Siemens dystrophic epidermolysis bullosa. Nat Genet (1993) 1.25

Syphilitic osteomyelitis with diffusely abnormal bone scan. Mt Sinai J Med (1979) 1.25

Tumor necrosis factor-alpha and interferon-gamma suppress the activation of human type I collagen gene expression by transforming growth factor-beta 1. Evidence for two distinct mechanisms of inhibition at the transcriptional and posttranscriptional levels. J Clin Invest (1990) 1.22